MetaCap

Cadre (CDRE) vs XPEL (XPEL)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

XPEL (XPEL) has outperformed Cadre (CDRE) over the past year, losing 13.7% versus a loss of 26.8%. Over five years, CDRE leads with a +51.0% price change compared with -47.1% for XPEL. Cadre is the larger company by market cap ($1.26 billion vs $1.05 billion), about 1.2 times the size, while XPEL is growing revenue faster (+13.3% vs +7.5%).

On valuation, XPEL trades at a lower forward P/E (14.8x vs 18.5x for Cadre). Cadre pays a dividend yielding 1.34%, while XPEL does not currently pay one. XPEL converts more of its revenue into profit, with a net margin of 10.8% versus 7.2%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CDRE-26.83%XPEL-13.74%
+28%-7%-42%
Nov 21, 20251 yearNov 20, 2026
CDRE+41.11%XPEL-49.58%
+122%+23%-75%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CDRE versus XPEL key metrics
MetricCDREXPEL
Share price$29.45$38.12
Market cap$1.26B$1.05B
1-day change-3.63%+1.36%
YTD return-27.89%-23.62%
1-year return-26.83%-13.74%
5-year return+51.03%-47.12%
P/E ratio (TTM)32.3618.15
Forward P/E18.5314.83
EPS (TTM)$0.91$2.10
Dividend yield1.34%0.00%
Annual dividend$0.395$0.00
Revenue (latest FY)$610.31M$476.20M
Revenue growth (YoY)+7.53%+13.27%
Net income (latest FY)$44.14M$51.23M
Gross margin42.54%42.21%
Operating margin11.04%13.16%
Net margin7.23%10.76%
52-week high$48.76$55.91
52-week low$24.07$36.00
Distance from 52-week high-39.60%-31.82%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+59.02%+49.53%
Average volume464.00K238.93K
Shares outstanding42.92M27.52M
Employees2,5331,337
SectorHealth CareIndustrials
IndustryIndustrial SpecialtiesIndustrial Specialties

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • XPEL has outperformed CDRE by 13.1 percentage points over the past year.
  • Cadre trades at a higher earnings multiple (32.4x vs 18.2x trailing P/E).
  • Cadre offers a meaningfully higher dividend yield (1.34% vs 0.00%).
  • XPEL grew revenue faster in its latest fiscal year (+13.27% vs +7.53%).
  • The two companies sit in different sectors: Cadre in Health Care and XPEL in Industrials.

About Cadre

CDRE stock →

Cadre Holdings, Inc. manufactures and distributes safety equipment and other related products that provides protection to users in hazardous or life-threatening situations in the United States and internationally.

Health Care · Industrial Specialties · 2,533 employees

About XPEL

XPEL stock →

XPEL, Inc. manufactures, installs, sells, and distributes protective films, coatings and related services.

Industrials · Industrial Specialties · 1,337 employees

CDRE vs XPEL FAQ

Which is bigger, Cadre or XPEL?

Cadre (CDRE) is larger, with a market capitalization of $1.26B compared with $1.05B for XPEL (XPEL).

Which stock has performed better over the past year, CDRE or XPEL?

XPEL returned -13.74% over the past 12 months, compared with -26.83% for CDRE (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, CDRE or XPEL?

XPEL has the lower trailing P/E at 18.2, versus 32.4 for CDRE. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Which pays a higher dividend, Cadre or XPEL?

Cadre pays a dividend yielding 1.34%, while XPEL does not currently pay a regular dividend.

Are Cadre and XPEL in the same industry?

Yes. Both are classified in the Industrial Specialties industry within the Health Care sector.

More comparisons